Kolexia
Blanc-Fournier Cecile Anatomie et cytologie
Blanc-Fournier Cecile
Anatomie et cytologie
Centre François-Baclesse
Caen, France
58 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de l'ovaire Tumeurs du sein Carcinomes Carcinome épithélial de l'ovaire Métastase lymphatique Tumeurs du sein triple-négatives Récidive tumorale locale Tumeurs du poumon Carcinome canalaire du sein

Collaborateurs

Voir plus
Joly Florence
Joly Florence
Hôpital Côte de Nacre, Caen, France
Levy Christelle
Levy Christelle
Centre François-Baclesse, Caen, France
Jeanne Corinne
Jeanne Corinne
Centre François-Baclesse, Caen, France
Berghian Anca-Viorica
Berghian Anca-Viorica
Centre Henri-Becquerel, Rouen, France

Industries

Voir plus
MSD
9 collaboration(s)
Dernière en 2023
Roche
1 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma.
Journal of experimental & clinical cancer research : CR   07 octobre 2023
The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer.
BMC cancer   19 septembre 2023
TRIPLEX: Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment
Essai Clinique (Centre François-Baclesse)   31 juillet 2023
112P Correlation between HER2-negative status and risk of recurrence according to PAM50 score
Abstract Book of ESMO Breast Cancer 2023, Berlin, Germany, 11-13 May 2023   01 mai 2023
Abstract 166: Comparative analysis of response to treatments and molecular features of patient-derived tumor organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma
Proceedings: AACR Annual Meeting 2023   01 avril 2023
Abstract 6112: Automated scoring to assess RAD51-mediated homologous recombination in patient-derived tumor organoids of ovarian cancers
Proceedings: AACR Annual Meeting 2023   01 avril 2023
HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer.
BMC cancer   20 octobre 2022
Impact of automated methods for quantitative evaluation of immunostaining: Towards digital pathology.
Frontiers in oncology   11 octobre 2022
104P HELENA: Study of HER2-low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer
Abstract Book of ESMO Breast Cancer 2022, Berlin, Germany, 03-05 May 2022   01 mai 2022
A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study.
Gynecologic oncology   02 février 2022